Experimental One-Dose Treatment Cuts 'Bad' Cholesterol by 52% in First Human Trial : ScienceAlertWeb Page - www.sciencealert.com
sciencealert.com

Experimental One-Dose Treatment Cuts 'Bad' Cholesterol by 52% in First Human Trial : ScienceAlert

Too much 'bad' cholesterol in the bloodstream – that's the low-density lipoprotein (LDL) type – can contribute to plaque buildup in the arteries, increasing the risk of cardiovascular problems like heart attacks and str…

This site doesn’t allow embedding inside another page — open it in a new tab. Your Weird rating still works from the top bar.

Open source